112 related articles for article (PubMed ID: 9192434)
1. Long-term results of ethanol embolization of renal cell carcinoma.
Saitoh H; Hayakawa K; Nishimura K; Kubo S; Hida S
Radiat Med; 1997; 15(2):99-102. PubMed ID: 9192434
[TBL] [Abstract][Full Text] [Related]
2. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
[TBL] [Abstract][Full Text] [Related]
3. Preoperative renal tumor embolization. A useful procedure?
Fischedick AR; Peters PE; Kleinhans G; Pfeifer E
Acta Radiol; 1987; 28(3):303-6. PubMed ID: 2958037
[TBL] [Abstract][Full Text] [Related]
4. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
5. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of postoperative interferon-alpha adjuvant therapy for non-metastatic renal cell carcinoma.
Gotoh A; Shirakawa T; Hinata N; Wada Y; Hara I; Fujisawa M; Kawabata G; Okada H; Arakawa S; Kamidono S
Int J Urol; 2004 May; 11(5):257-63. PubMed ID: 15147539
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
[TBL] [Abstract][Full Text] [Related]
8. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
Klatte T; Patard JJ; Wunderlich H; Goel RH; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
J Urol; 2007 Jun; 177(6):2081-6; discussion 2086-7. PubMed ID: 17509291
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
10. [Renal arterial embolization for renal cell carcinoma].
Yamasaki Y; Tochigi H; Tajima K; Yanagawa M; Hayashi N; Sakurai M; Yamakawa K; Tada S; Nakamura K; Hirano T
Hinyokika Kiyo; 1985 Mar; 31(3):387-95. PubMed ID: 4025078
[TBL] [Abstract][Full Text] [Related]
11. [Transcatheter arterial embolization of renal carcinoma with absolute ethanol].
Li B; Li Y; Yang H; Wang J; Li Y; Li W; Liu S
Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):462-3. PubMed ID: 11829889
[TBL] [Abstract][Full Text] [Related]
12. [Long-term results of endovascular treatment of metastatic renal cell cancer].
Granov AM; Gorelov AI; Shumskiĭ IA; Polikarpov AA; Shkol'nik MI; Vorob'ev MI; Karelin MI
Vestn Rentgenol Radiol; 1999; (6):20-3. PubMed ID: 10714226
[TBL] [Abstract][Full Text] [Related]
13. [Results of endovascular interventions (embolization and chemoembolization) in the treatment of operable and extensive kidney cancer].
Granov AM; Gorelov AI; Gershanovich ML; Karelin MI; Vorob'ev AV; Filov VA; Stukov AN
Vopr Onkol; 1998; 44(6):711-4. PubMed ID: 10087971
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
15. [A clinical study of renal cell carcinoma].
Uchida T; Izumi H; Kobayashi K; Arakawa T; Honda N; Omata T; Odajima K; Mashimo S; Endo T; Ishibashi A
Hinyokika Kiyo; 1985 Nov; 31(11):1919-25. PubMed ID: 4091134
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.
Figlin R; Gitlitz B; Franklin J; Dorey F; Moldawer N; Rausch J; deKernion J; Belldegrun A
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S92-7. PubMed ID: 9457402
[TBL] [Abstract][Full Text] [Related]
17. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
18. [Effect of kidney occlusion on survival in renal cell carcinoma: a 10-year retrospective study].
Latal D; Kautzky W; Wanek R; Kumpan W
Z Urol Nephrol; 1990 Jan; 83(1):27-31. PubMed ID: 2330762
[TBL] [Abstract][Full Text] [Related]
19. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
[TBL] [Abstract][Full Text] [Related]
20. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
